Researchers at the University of California, San Francisco (UCSF), have elucidated the biological mechanism behind the common phenomenon of appetite suppression during infections, particularly parasitic worm infestations, which affect millions globally, including in India where helminth infections remain prevalent. This breakthrough, published in *Nature* on March 25, reveals how the gut’s immune response communicates with the brain to alter eating behavior. Led by Nobel laureate David Julius, PhD, and immunologist Richard Locksley, MD, the study identifies a novel signaling pathway involving two specialized gut cell types: tuft cells and enterochromaffin (EC) cells. Tuft cells, which detect parasites via compounds like succinate, release acetylcholine—a neurotransmitter typically associated with neurons—in a biphasic manner. An initial short burst occurs upon detection, followed by a sustained release as the infection persists and tuft cell numbers increase. This acetylcholine stimulates EC cells to secrete serotonin, which activates vagal nerve fibers, transmitting signals to the brain and inducing nausea, discomfort, and reduced appetite. This delayed response explains why appetite loss often manifests after initial symptoms, allowing the body to confirm a genuine threat before behavioral changes.
The findings have significant implications for clinical practice, especially in tropical regions like India, where chronic parasitic infections contribute to malnutrition and growth stunting. By demonstrating that genetically modified mice lacking acetylcholine production in tuft cells maintained normal eating despite infection, the study confirms the pathway’s direct role in appetite regulation. Beyond parasites, this mechanism may underlie various gastrointestinal disorders, including irritable bowel syndrome (IBS), food intolerances, and chronic visceral pain, as tuft cells are present in other organs like the airways and gallbladder. For Indian doctors, this could inform targeted therapies to modulate tuft cell outputs, potentially alleviating symptoms in patients with persistent gut issues or post-infectious anorexia. Collaborations with experts like Stuart Brierly, PhD, from the University of Adelaide, highlight the pathway’s broader relevance, suggesting applications in managing immune-mediated digestive complaints without broadly suppressing immunity. This research underscores the elegant interplay between the immune and nervous systems, offering a foundation for novel interventions in infection-related morbidity.
